Search
Showing results for "1"
News & Events
Self-efficacy groups 2020Perth Children’s Hospital’s Diabetes Service has released the dates for its self-efficacy groups for 2020.
News & Events
Diabete$ Re$earch in Au$traliaIt may surprise you to know that the Australian government has invested almost $300 million dollars since 2000 towards research and clinical trials for diabetes
Research
Gut microbiome and innate immune response patterns in IgE-associated eczemaGut microbiome patterns have been associated with predisposition to eczema potentially through modulation of innate immune signalling.
Research
Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086Assessment of the persistence of bactericidal antibodies up to 4 years after a three-dose schedule of bivalent rLP2086
Research
Pediatric hospital admissions in Indigenous children: A population-based study in remote AustraliaWe analysed hospital admissions of a predominantly Aboriginal cohort of children in the remote Fitzroy Valley in Western Australia during their first 7 years.
News & Events
Launching TRACE T1DWe are excited to launch this first-of-its-kind Australian study, monitoring glucose levels in Australian children and adolescents who have tested positive to having one or more type 1 diabetes related antibodies but do not yet need treatment with insulin.
Research
HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptomsHLA-A*32:01 is strongly associated with vancomycin-induced DRESS in a population of predominantly European ancestry
Research
Risk factors for group A streptococcal pharyngitis and skin infections: A case control studyGroup A streptococcal (GAS) infections can trigger an immune-mediated response resulting in acute rheumatic fever. The role of social and environmental risk factors for GAS pharyngitis and skin infections are not well understood.
Research
Advances in Automated Insulin Delivery with the Medtronic 780G: The Australian ExperienceTo assess the real-world performance of MiniMed™ 780G for Australians with type 1 diabetes (T1D) following advanced hybrid closed loop (AHCL) activation and to evaluate the effect of changing from MiniMed 670/770G to 780G.
Research
Copeptin Kinetics and Its Relationship to Osmolality During Rehydration for Diabetic Ketoacidosis in ChildrenCopeptin is a surrogate marker for arginine vasopressin (AVP) release in response to hyperosmolal stimuli such as diabetic ketoacidosis (DKA). The objective of this work is to characterize kinetics of copeptin and osmolality, and their dynamic relationship during rehydration and insulin therapy in children with type 1 diabetes (T1D) and DKA.